Mutations in RPGR (retinitis pigmentosa GTPase regulator) are the most common cause of X-linked RP, a severe blindness disorder. RPGR mutations result in clinically variable disease with early-to late-onset phenotypic presentation. Molecular mechanisms underlying such heterogeneity are unclear. Here we show that phenotypic expression of Rpgr-loss in mice is influenced genetically by the loss of Cep290, a human ciliopathy gene. We found that Rpgr ko/Y mice with a heterozygous hypomorphic allele of Cep290 (Cep290 rd16/+ ) but not of a heterozygous null allele of Cep290 (Cep290 null/+ ) or of other ciliopathy genes, Rpgrip1, Nphp1, Nphp4 and Nphp5, exhibit relatively early onset (by 3 months of age) retinal degeneration and dysfunction when compared with the onset at ∼7 months of age in the Rpgr ko/Y mice. We also observed disorganized photoreceptor outer-segment morphology and defective trafficking of opsins in the Rpgr ko/Y ::Cep290 rd16/+ mice. Together with a physical interaction between RPGR and the C-terminal domain of CEP290, our data suggest that RPGR and CEP290 genetically interact and highlight the involvement of hypomorphic alleles of genes as potential modifiers of heterogeneous retinal ciliopathies.
Introduction
Retinitis Pigmentosa (RP) is a debilitating inherited blindness disorder, which results in a progressive and severe loss of rod and cone photoreceptors (1, 2) . X-linked forms of RP (XLRP) are the most severe forms of RP characterized by the loss of photoreceptor function starting as early as in the first decade of life and progressing into complete blindness by the third or fourth decade (3) (4) (5) . Mutations in two genes, RPGR and RP2, account for a majority of XLRP cases (6) (7) (8) . Of these, RPGR mutations are associated with >70% of XLRP and 15-20% of simplex RP cases, making it a common cause of RP worldwide (5, 6, 9, 10) .
Genotype-phenotype correlation studies revealed that RPGR mutations result in variable clinical manifestation with mild to severe rod followed by cone photoreceptor loss or a predominantly cone-rod degeneration (11) (12) (13) . Moreover, even patients with same mutations exhibit heterogenic clinical phenotype, suggesting the influence of genetic modifiers (14) . Variable severity associated with RPGR mutations is also recapitulated in animal models of Rpgr. The Rpgr ko mouse, generated by deleting exons 4-6 (15) , undergoes relatively delayed onset (around 7 months of age) retinal degeneration and mild defects in the trafficking of opsins to the light-sensing outer segment (OS; sensory cilium) compartment of photoreceptors. A naturally occurring Rpgr mutant mouse model rd9 (retinal degeneration 9) and a conditional allele of Rpgr exhibit a moderate progressing retinal degenerative disease (5, 16) . Two canine models of RPGR mutation, XLPRA1 and XLPRA2 have also been characterized. Whereas XLPRA1 exhibits a relatively mild phenotype, the XLPRA2 canine model undergoes a severe and fast progressing retinal degeneration (17) . Here, we sought to identify potential genetic modifiers of RPGR-associated retinal degeneration. Genetic modifiers should meet the criteria of being able to interact with the causative gene and of being themselves involved in retinal degeneration (18, 19) . RPGR is a ciliary protein and interacts with autosomal recessive ciliopathy-associated proteins, such as RPGR-interacting protein1 (RPGRIP1), CEP290 and Nephronophthisis (NPHP)-associated proteins NPHP1, NPHP4 and NPHP5 in mammalian retina (20) (21) (22) (23) (24) (25) (26) . In this study, we assessed the effect of heterozygous alleles (not disease-causing by themselves) of these RPGR-interacting proteins on the progression of retinal degeneration in the Rpgr ko mice. (20, 29) . This mutation is hypomorphic as the deleted variant of the CEP290 protein (ΔCEP290) lacking amino acids 1599-1897 is still expressed in these mice (20, 29 
Results

Generation and characterization of
Physical interaction between RPGR and CEP290
We had previously shown that RPGR and CEP290 are part of multi-protein complexes in mouse photoreceptors (20, 23) . Given a potential genetic modification of RPGR-associated disease by CEP290, we investigated the interaction of human RPGR with human CEP290. To this end, we generated mammalian expression constructs encoding recombinant full-length SBP (Streptavidin-Binding Protein)-tagged human RPGR and GFPtagged full length and deleted variants of human CEP290 (Fig. 5A) . We then tested the interaction of recombinant RPGR and CEP290 proteins in a co-transfection followed by co-immunoprecipitation (IP) assay. As shown in Figure 5B , IP of protein extracts from cells expressing SBP-RPGR and full-length GFP-CEP290 using anti-SBP antibody followed by immunoblotting revealed anti-GFP immunoreactive bands. IP using control immunoglobulin did not reveal any signal. We then sought to determine the region of CEP290 that interacts with RPGR. Co-IP assay revealed GFP-immunoreactive bands only in the samples from cells expressing CEP290-1751-2050 amino acids and CEP290-2037-2479 amino acids but not in the samples expressing GFP-CEP290-883X, GFP-CEP290-580-1615 or GFP-CEP290-1615-1751 ( Fig. 5C-E) , indicating that the C-terminal domain of CEP290 is involved in its binding to RPGR. It should be noted that a lack of detectable interaction with GFP-CEP290-883X and GFP-CEP290-580-1615 may be because of relatively lower levels of the encoded proteins, likely due to their labile nature. Potential effect of the involvement of additional regions of CEP290 in its interaction with RPGR is discussed in the next section.
Discussion
In this study, we investigated the involvement of genetic modifiers in modulating the severity of XLRP due to RPGR. We found that the severity of RPGR-associated disease and effect on opsin trafficking are exacerbated by the presence of a single copy of the hypomorphic Cep290 rd16 allele. Loss of a single copy of none of the other tested NPHP proteins or RPGRIP1 affected the severity of RPGR disease in mice. Our data, therefore, suggest that distinct combinations of multiprotein complexes are involved in optimal ciliary trafficking of proteins in photoreceptors. Earlier studies have revealed that genetic interactions between distinct ciliopathy protein complexes can alter ciliary trafficking and function (27, 38) . As CEP290 and RPGR are part of several protein complexes, including BBS and MKS proteins (20) (21) (22) 35, (39) (40) (41) (42) (43) and both RPGR and CEP290 function at the ciliary TZ likely by regulating the entry or exit of cargo (32, 34, 44) , our studies suggest that functional interactions across distinct ciliopathy protein complexes may collaborate to maintain photoreceptor ciliary architecture and function. It is possible that the differences in the genetic backgrounds and associated unknown modifiers mice may play a role in the interpretation of our data. However, we did not observe any effect on RPGR disease in the Rpgr (mixed C57BL6/J and 129Sv/Ev) mice, suggesting that the mixed background also may not affect the retinal phenotype. All other mouse mutants including the Rpgr ko mice are in C57BL6/J background. However, a subtle involvement of other genetic modifiers or additional allelic combinations of RPGR-interacting proteins may alter the severity (exacerbate or protect) of RPGR-associated disease. Additional studies are needed to test these possibilities. An interesting observation in our study was that insufficiency of CEP290 (Cep290 null/+ ) did not affect the progression of RPGR-associated dysfunction. Thus, predicted hypomorphic alleles of CEP290 in patients are potential candidates for genetic interaction with RPGR. Previous reports also showed the involvement of hypomorphic in genes (including RPGRIP1L and AHI1) as modifiers of retinal degeneration in ciliopathies (18, 19, 27) . The additional Nphp and Rpgrip1 alleles tested in this study are also null alleles. Thus, it is possible that hypomorphic variants in these proteins can affect the severity of RPGR-associated disease.
We found that RPGR preferentially binds to the C-terminus of CEP290 ( preferentially between amino acids 2037 and 2050), which does not coincide with its microtubule/membrane-binding domain (amino acids 1695-1966) (45) or NPHP5-binding domain (amino acids 696-896) (46) (Fig. 5A) . We, however, cannot exclude the possibility that other regions of CEP290 provide a stabilizing or inhibitory domain for interaction with RPGR. Support of this hypothesis comes from two previous observations: (i) absence of the DRD in the Cep290 rd16/rd16 mice results in increased association with RPGR and sequestration of RPGR in the IS of photoreceptors (20) ; and (ii) the N-and C-terminal domains of CEP290 can form homo-or heterodimers, assisting in regulating the function of its binding proteins (46) . How might ΔCEP290 alter photoreceptor function in the Rpgr ko mice? We and others have shown that CEP290 interacts with other ciliary proteins, including NPHP5, BBS4, BBS6, MKS proteins and RKIP (29, 35, (39) (40) (41) (42) . The ΔCEP290 variant although no longer interacts with BBS6 or RKIP, can still associate with BBS4, and likely with NPHP5. Thus, the ΔCEP290 protein may exacerbate the dysfunction of the ciliary gate in the Rpgr ko mice by perturbing the organization or composition of the multiprotein complexes (47, 48) . A model representing this hypothesis is depicted in Figure 5F . As RPGR interacts with NPHP proteins (22, 23, 26) , such effects are probably tolerated in the presence of RPGR. Further studies are needed to test this hypothesis. Overall, our studies suggest that RPGR-CEP290 complexes may be distinct in composition and/or function when compared with complexes of RPGR with NPHP-associated proteins and with RPGRIP1. Hence, investigations of the discrete complexes of ciliopathy proteins in a tissue-specific manner may hold key to understand the pleiotropic nature of such devastating diseases. (15, 20, 25, 27, 28) . The Nphp5 −/− mice were genotyped using Nphp5 F: (5′<CCTTTAGGGTGATAGTAGCCAATTCC 3′>), Nphp5 R: wt (5′<AGGAACTAAGCTGTGAAATGGACC 3′>) and Nphp5 mut (5′<CAACGGGTTCTTCTGTTAGTCC 3′>) primers. The WT allele produced a PCR product of 452 bp, whereas the mutant allele produced a 294 bp pCR product. Scotopic and photopic ERG was performed as previously reported (49) . For each experiment, five mice of each genotype were used.
Materials and Methods
Mice and ERG
Antibodies and plasmids
Antibody against rhodopsin was procured from EMD Millipore (Billerica, MA). The anti-M-opsin antibody was a gift of Dr Cheryl M. Craft (University of Southern California) (50) . Ant-GFP and anti-SBP antibodies were obtained from Abcam (Cambridge, MA) and Agilent technologies (La Jolla, CA); anti-CENTRIN-2 was procured from Sigma and anti-BBS6 was obtained from Abnova. Anti-NPHP1 was kindly provided by Dr Gregory Pazour (UMASS Medical School). Constructs encoding GFP-tagged CEP290 fragments and SBP-tagged RPGR were generated by cloning human CEP290 or RPGR in pEGFPN1 (Clontech, Mountain View, CA) and pNTAP (Agilent technologies). Fragments encoding variants of RPGR and CEP290 were obtained by site-directed mutagenesis.
Cell culture, transfection and immunoprecipitation assays HEK293 cells were maintained at 37°C with 5% CO 2 in DMEM (Invitrogen) supplemented with 10% fetal bovine serum and penicillin/streptomycin. Transient transfection was carried out using Lipofectamine 2000 (Invitrogen) in serum-free medium, as described (21) . Transfected cells were lysed and proteins harvested in phosphate buffered saline ( pH 7.4) containing protease inhibitors. Samples were subjected to co-IP as described (21) or according to manufacturer's instructions (Agilent Technologies).
Immunofluorescence and TEM analyses
Mouse eyes were enucleated and fixed with 4% paraformaldehyde in PBS followed by cryosectioning and staining, as previously described (51) . For TEM analysis, enucleated eyes were fixed in 2% glutaraldehyde, 2% paraformaldehyde in 0.1 M sodium cacodylate buffer ( pH 7.2). The samples were processed as described previously (51) .
Supplementary Material
Supplementary Material is available at HMG online.
immunofluorescence and preparation of the figure depicting the model of RPGR-CEP290 association.
